Anna Alonso-Solís
Impact in
- Cognitive Neuroscience top 5%
- Functional Brain Connectivity Studies
- Neural dynamics and brain function
- Neuroscience and Music Perception
Papers in
-
- Schizophrenia research and treatment 8
-
- Digital Mental Health Interventions 3
- Co-authors
- Iluminada CorripioEnric ÁlvarezMarı́a J. PortellaEva GrasaAlexandra RoldánMireia RabellaBeatriz Gómez‐AnsónVíctor Pérez
- Journals
- Schizophrenia Research (4 papers)Journal of Psychiatric Research (3 papers)European Neuropsychopharmacology (2 papers)European Psychiatry (1 paper)EBioMedicine (1 paper)
- Partner nations
- SpainUnited StatesFinland
In The Last Decade
Anna Alonso-Solís
20 papers receiving 418 citations
Peers
Comparison fields: 5 of 64
- Cognitive Neuroscience 258
- Biological Psychiatry 22
- Psychiatry and Mental health 123
- Radiology, Nuclear Medicine and Imaging 120
- Neurology 79
Countries citing papers authored by Anna Alonso-Solís
This map shows the geographic impact of Anna Alonso-Solís's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Alonso-Solís with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Alonso-Solís more than expected).
Fields of papers citing papers by Anna Alonso-Solís
This network shows the impact of papers produced by Anna Alonso-Solís. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Alonso-Solís. The network helps show where Anna Alonso-Solís may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna Alonso-Solís, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 5 | |
| 2 | 2023 | 3 | |
| 3 | 2022 | 6 | |
| 4 | 2021 | 14 | |
| 5 | 2021 | 7 | |
| 6 | 2020 | 11 | |
| 7 | 2020 | 61 | |
| 8 | 2020 | 3 | |
| 9 | 2019 | 18 | |
| 10 | 2018 | 13 | |
| 11 | 2018 | 10 | |
| 12 | m-RESIST, a complete m-Health solution for patients with treatmentresistant schizophrenia: a qualitative study of user needs and acceptability in the Barcelona metropolitan area. | 2017 | 9 |
| 13 | 2017 | 45 | |
| 14 | 2017 | 23 | |
| 15 | 2014 | 101 | |
| 16 | [Olanzapine long-acting post-injection syndrome: a case report and brief review]. | 2014 | 2 |
| 17 | 2012 | 53 | |
| 18 | 2012 | 15 | |
| 19 | 2011 | 17 | |
| 20 | La Cova de Gargán, Xodos (Castelló de la Plana) | 1983 | 1 |
About Anna Alonso-Solís
Anna Alonso-Solís is a scholar working on Psychiatry and Mental health, Applied Psychology, Cognitive Neuroscience, Cellular and Molecular Neuroscience and Neurology, having authored 21 papers that have together received 428 indexed citations. Recurring topics across this work include Functional Brain Connectivity Studies (8 papers), Schizophrenia research and treatment (8 papers), Neurological disorders and treatments (5 papers), Advanced Neuroimaging Techniques and Applications (5 papers), Genetic Neurodegenerative Diseases (5 papers), Parkinson's Disease Mechanisms and Treatments (4 papers), Neural dynamics and brain function (3 papers) and Digital Mental Health Interventions (3 papers). The work is most often cited by research in Cognitive Neuroscience (258 citations), Biological Psychiatry (22 citations), Psychiatry and Mental health (123 citations), Radiology, Nuclear Medicine and Imaging (120 citations) and Neurology (79 citations). Anna Alonso-Solís has collaborated with scholars based in Spain, United States and Finland. Frequent co-authors include Iluminada Corripio, Enric Álvarez, Marı́a J. Portella, Eva Grasa, Alexandra Roldán, Mireia Rabella, Beatriz Gómez‐Ansón, Víctor Pérez, Yolanda Vives‐Gilabert and Edith Pomarol‐Clotet. Their work appears in journals such as Schizophrenia Research, Journal of Psychiatric Research, European Neuropsychopharmacology, European Psychiatry and EBioMedicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.